Patent US3826258A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3826258A Expired / Lapsed US ⏱️ 0.0 years remaining

Gradual release medicine carrier

Assignee: Individual
•
Filing: 1972-02-07
•
Granted: 1974-07-30
•
Expires: 1992-02-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A medicament carried within a perforate or semipermeable shell is gradually released, as by dissolution into body fluids, to provide effective therapy with reduced concentration and dosage. The medicament may be in dry powdered form. For treatment of the eye, the carrier comprises a capsule less than 1 millimeter in diameter which is placed in the conjunctival sac or mounted in a contact lens. The capsule may be colored for easy location and removal, may be absorbable by the body, or may gradually swell to allow washout by the tears. For glaucoma treatment, less than 1 milligram of pilocarpine or phospholine in a single sustained release capsule may be an adequate daily dosage. In another embodiment a soft contact lens itself may serve as the medicine containing carrier. For burn, ulcer, or wound treatment, the carrier may be of planar configuration or incorporated in a film forming spray comprising many minute particles or capsules each containing a medicament. The resultant film will protect the tissue from exposure, will provide sustained release medication, and may be absorbable to eliminate the need for removal with concomitant damage to newly formed granulation tissue.

Inventors

  • 👤 S Abraham

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:11
CPC Classifications
A; A61; A61F; A61F9/00; A61F9/0008; A61F9/0017; A61K; A61K9/00; A61K9/0012; A61K9/0048; A61K9/0051

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 35 words
A prepackaged ampoule-like dropper according to claim 1 wherein said casing is absorbable by tissue of said conjunctival sac over a time duration commensurate with or greater than the total release period of said medicament.
Claim 2
Dependent Claim 25 words
A prepackaged ampoule-like dropper according to claim 1 wherein said carrier is colored to aid finding the emptied casing for removal from said conjunctival sac.
Claim 3
Dependent Claim 32 words
A prepackaged ampoule-like dropper according to claim 1 wherein said casing gradually swells in the presence of tears to a size sufficient to be washed from said conjunctival sac by said tears.
Claim 4
Dependent Claim 34 words
A prepackaged ampoule-like dropper according to claim 1 wherein said medicament comprises less than 1 milligram of pilocarpine or phospholine, said medicament being a sufficient daily dosage for the sustained release treatment of glaucoma.

References Cited (Backward Citations)

US2898911A Cited
US3185625A Cited
US3416530A Cited
US3485244A Cited
US3618604A Cited
US3630200A Cited
US3625214A Cited
US3641237A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1977-07-29 1978-01-28 1978-07-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1981-07-29 1982-01-28 1982-07-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1985-07-29 1986-01-28 1986-07-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag